1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) ForumMotherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
I really don't know what to do. I am 25 years old and would like to have another child, but I was so sick during my first pregnancy that I'm afraid to get pregnant again. My symptoms got so bad that my doctor had me hospitalized for a while because I got dehydrated from the constant vomiting. I want another child but I don't know if I could face that again. Please help me.
Motherisk researchers have shown that treating nausea and vomiting of pregnancy (NVP) before the appearance of symptoms can prevent severe NVP and hyperemesis gravidarum. This research is recently reported in the Journal of Obstetric Gynaecology 2004.
The Motherisk study looked at 25 women who had severe NVP or hyperemesis in a previous pregnancy, and counseled them to take Diclectin while planning their next pregnancy (before conception) or very early in the pregnancy before the appearance of NVP symptoms.
The women in the study group were compared to a group of randomly selected women who also had severe NVP, but who did not call the Motherisk NVP Helpline for counseling before they conceived, and therefore could not be offered pre-emptive therapy.
The majority of the women in the study group experienced far less severe NVP symptoms during the index pregnancy, compared to their previous pregnancy. Symptoms among women in the comparison group remained severe in 80% of the cases.
This study confirms that severe NVP can be prevented with pre-emptive treatment.